Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Reinreude Tag Wart Remover

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Salicylic Acid 40 g/100 1
Other brand names
Dosage form
Patch
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2024
Label revision date
January 3, 2025
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Salicylic Acid 40 g/100 1
Other brand names
Dosage form
Patch
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2024
Label revision date
January 3, 2025
Manufacturer
Jiangxi Hemei Pharmaceutical Co. , Ltd
Registration number
M028
NDC root
84010-063
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

You can use this medication to help remove warts and corns, which are common skin growths. Warts are caused by a virus, while corns are thickened areas of skin that develop due to pressure or friction. This treatment works by targeting these growths, helping to eliminate them and restore smoother skin. If you're dealing with warts or corns, this medication may be a suitable option for you.

Uses

You can use this medication to help remove warts and corns from your skin. Warts are small growths caused by a virus, while corns are thickened areas of skin that often develop on your feet due to pressure or friction. This treatment is specifically designed to target these skin issues effectively.

It's important to note that there are no known harmful effects on pregnancy (teratogenic effects) or any other non-harmful effects mentioned with this medication. Always consult with your healthcare provider for personalized advice and to ensure this treatment is right for you.

Dosage and Administration

To start treating your wart, first wash the affected area thoroughly. You may also choose to soak the wart in warm water for about 5 minutes to help soften it, but make sure to dry the area completely afterward. If the medicated plaster doesn’t fit the wart perfectly, you can cut it to size.

Once you have the plaster ready, apply it directly to the wart. For the best results, repeat this process every 48 hours as needed, but do not continue for more than 12 weeks. This routine will help you effectively manage the wart over time.

What to Avoid

You should avoid using this product on any irritated, infected, or reddened skin, as well as on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. It is also important not to apply it to mucous membranes, which are the moist tissues lining certain body cavities.

When using the product, be careful to keep it away from your eyes and face. If it accidentally gets into your eyes, rinse them thoroughly with water. Following these guidelines will help ensure your safety and the effectiveness of the treatment.

Side Effects

It's important to note that this product is for external use only. If you experience any discomfort that continues, you should stop using it. Additionally, if you have diabetes or poor blood circulation, it's a good idea to consult with your doctor before using this product to ensure it's safe for you.

Warnings and Precautions

This product is intended for external use only. If you accidentally swallow it, seek medical help or contact a Poison Control Center immediately.

Avoid using this product on any skin that is irritated, infected, or reddened. It should not be applied to genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them, nor should it be used on mucous membranes (the moist tissue lining certain body cavities). If you experience ongoing discomfort while using this product, stop using it and call your doctor for further advice.

Overdose

If you suspect an overdose of this medication, it's important to stay calm and take immediate action. While the drug insert does not provide specific information about overdose, you should be aware of general signs that may indicate an overdose, such as unusual drowsiness, confusion, or difficulty breathing.

If you notice any of these symptoms, or if you are unsure whether an overdose has occurred, seek medical help right away. Contact your healthcare provider or go to the nearest emergency room. It's always better to be safe and get professional assistance if you have concerns about your health.

Pregnancy Use

There is currently no information available about the use of REINREUDE TAG WART REMOVER (salicylic acid 40% tag wart remover patch) during pregnancy. This means that safety concerns, dosage adjustments, or any special precautions for pregnant individuals have not been addressed in the product's guidelines.

If you are pregnant or planning to become pregnant, it is important to consult with your healthcare provider before using this product to ensure it is safe for you and your baby. Always prioritize your health and the health of your child when considering any treatments.

Lactation Use

If you are breastfeeding or planning to breastfeed, it's important to talk to your healthcare professional before using this product. There is a possibility that it can be passed into breast milk, so caution is recommended.

The effects on your nursing infant have not been thoroughly studied, which means you should carefully weigh the potential risks against the benefits before making a decision. Your health and your baby's well-being are the top priorities, so seeking professional advice is essential.

Pediatric Use

It's important to keep this medication out of reach of children to prevent accidental ingestion. If your child swallows any of it, seek medical help immediately or contact a Poison Control Center for guidance. Taking these precautions can help ensure your child's safety.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider before starting the medication. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment plan is safe and effective for your specific situation. They can help monitor your kidney health and make any necessary adjustments to your medications.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (liver issues).

Always consult your healthcare provider for personalized advice and to discuss any concerns regarding your liver health and how it may relate to your treatment. They can help ensure that you receive the safest and most effective care.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking, even if there are no known drug interactions or laboratory test interactions associated with them. This ensures that your treatment plan is safe and effective for your individual health needs.

Always keep your healthcare team informed about all the medications and supplements you use, as well as any lab tests you may undergo. This way, they can provide the best care tailored to you.

Storage and Handling

To ensure the best performance and safety of your product, store it in a cool, dry place where the temperature remains between 59°F and 86°F (15°C and 30°C). This temperature range helps maintain the integrity of the device.

When handling the product, be sure to do so with clean hands and in a sterile field (a clean area free from germs) to prevent contamination. Always follow any specific disposal instructions provided to ensure safe and responsible disposal of any components.

Additional Information

You will apply this medication topically, meaning you will apply it directly to the skin. You can repeat the application every 48 hours as needed, but do not use it for more than 12 weeks. There are no additional details regarding laboratory tests, abuse potential, or patient counseling information available at this time.

FAQ

What is the drug used for?

The drug is used for the removal of warts and corns.

How should I apply the medicated plaster?

First, wash the affected area. Optionally, soak the wart in warm water for 5 minutes and dry it thoroughly. If needed, cut the plaster to fit the wart and apply it.

How often should I use the plaster?

You should repeat the application every 48 hours as needed, for up to 12 weeks.

Are there any contraindications for using this drug?

Do not use it on irritated, infected, or reddened skin; on genital warts or warts on the face; on moles, birthmarks, or warts with hair growing from them; or on mucous membranes.

What should I do if I experience discomfort?

Stop using the product if discomfort persists.

Is this drug safe to use during pregnancy?

There is no specific information regarding the safety of this drug during pregnancy, so consult a healthcare professional.

Can nursing mothers use this product?

Nursing mothers should consult a healthcare professional before using this product, as there is a potential for excretion in breast milk.

What should I do if the product gets into my eyes?

If the product gets into your eyes, rinse thoroughly with water.

What should I do if I swallow the product?

If swallowed, get medical help or contact a Poison Control Center right away.

How should I store this drug?

Store the drug between 59°F and 86°F (15°C and 30°C).

Packaging Info

Below are the non-prescription pack sizes of Reinreude Tag Wart Remover (salicylic acid 40% tag wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Reinreude Tag Wart Remover.
Details

Drug Information (PDF)

This file contains official product information for Reinreude Tag Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the removal of warts and corns.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

The affected area should be washed thoroughly prior to application. Optionally, the wart may be soaked in warm water for 5 minutes to facilitate treatment; after soaking, the area must be dried thoroughly. If necessary, the medicated plaster can be cut to fit the size of the wart.

The medicated plaster should be applied directly to the wart. This application may be repeated every 48 hours as needed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

  • Application on irritated, infected, or reddened skin is prohibited due to the potential for exacerbating the condition.

  • The product should not be used on genital warts or warts located on the face, as these areas may be sensitive and prone to adverse reactions.

  • Avoid application on moles, birthmarks, or warts with hair growing from them, as this may lead to irritation or complications.

  • The product is contraindicated for use on mucous membranes, given the risk of irritation and adverse effects.

Additionally, contact with the eyes or face should be strictly avoided. In the event of accidental exposure to the eyes, it is essential to rinse thoroughly with water.

Warnings and Precautions

For external use only. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

This product is contraindicated for use on irritated, infected, or reddened skin. It should not be applied to genital warts, facial warts, moles, birthmarks, or any warts exhibiting hair growth. Additionally, it is not intended for application on mucous membranes.

Healthcare professionals are advised to instruct patients to discontinue use if discomfort persists, and to seek further medical evaluation if necessary.

Side Effects

For external use only. Patients should discontinue use if discomfort persists. It is advised that individuals with diabetes or poor blood circulation consult a doctor prior to use.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Reinreude Tag Wart Remover (salicylic acid 40% tag wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Reinreude Tag Wart Remover.
Details

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is currently no information available regarding the use of REINREUDE TAG WART REMOVER (salicylic acid 40% tag wart remover patch) during pregnancy. This includes any safety concerns, dosage modifications, or special precautions that may be necessary for pregnant patients. Healthcare professionals are advised to exercise caution and consider the lack of data when prescribing this product to women of childbearing potential. It is recommended that the potential risks and benefits be carefully weighed in the context of individual patient circumstances.

Lactation

Nursing mothers should consult a healthcare professional before using this product. There is a potential for excretion in breast milk; therefore, caution is advised when administering to nursing mothers. The effects on the nursing infant are not well studied; thus, the risks versus benefits should be considered.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage in the available sections of the drug insert, healthcare professionals are advised to exercise caution when administering the medication.

Should an overdosage occur, it is essential to monitor the patient closely for any potential symptoms that may arise, although these symptoms are not explicitly detailed in the current documentation.

Management of overdosage should be guided by standard medical practices, including supportive care and symptomatic treatment as necessary. Healthcare providers are encouraged to consult local poison control centers or relevant medical authorities for further guidance on managing suspected overdosage cases.

In summary, due to the lack of detailed overdosage information, vigilance and adherence to established medical protocols are paramount in ensuring patient safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to instruct patients not to use the product on irritated, infected, or reddened skin, as well as on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, patients should be informed to avoid applying the product to mucous membranes.

Patients should be counseled to discontinue use if discomfort persists and to avoid contact with the eyes or face. In the event that the product comes into contact with the eyes, they should rinse thoroughly with water. Furthermore, healthcare providers should recommend that patients consult a doctor if they have diabetes or poor blood circulation before using the product.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within the temperature range of 59°F to 86°F (15°C to 30°C) to maintain its efficacy and integrity. Proper storage conditions must be adhered to, ensuring that the product is kept in a suitable environment to prevent degradation.

Additional Clinical Information

The product is administered topically and may be repeated every 48 hours as needed, for a duration of up to 12 weeks. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Reinreude Tag Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Reinreude Tag Wart Remover, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.